Algal DHA+Probio GG 2B
Natural health product licensed in Canada
- Other names
- Algal DHA+L rhamnosus GG 2B
- Licence holder
- Prébionature Inc.
- NPN or DIN-HM
- 80129318
- Status
- Active licence
- Licence date
- 1 February 2024
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Phosphate de potassium monobasique, Dioxyde de silicium, Ascorbate de sodium, Mélange de concentré de tocophérols, Phosphate de dipotassium, Chlorure de sodium, Huile de graines d'Helianthus annuus (Tournesol)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et nourrissons | maximum: 3 months | 0.5 mL | minimum: 1 par jour ; maximum: 2 par jour |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Source of docosahexaenoic acid (DHA) for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80129318
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.